CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotric-Furlan, S.
Right arrow Articles by Strle, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotric-Furlan, S.
Right arrow Articles by Strle, F.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 899-903, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.899-903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Clinical and Serological Follow-Up of Patients with Human Granulocytic Ehrlichiosis in Slovenia

Stanka Lotric-Furlan,1,* T. Avsic-Zupanc,2 M. Petrovec,2 W. L. Nicholson,3 J. W. Sumner,3 J. E. Childs,3 and F. Strle1

Department of Infectious Diseases, University Medical Centre1, and Institute of Microbiology and Immunology, Medical Faculty,2 University of Ljubljana, Ljubljana, Slovenia, and Viral and Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia3

Received 29 January 2001/Returned for modification 27 March 2001/Accepted 7 June 2001

An evaluation of the clinical outcome and the duration of the antibody response of patients with human granulocytic ehrlichiosis (HGE) was undertaken in Slovenia. Adult patients with a febrile illness occurring within 6 weeks of a tick bite were classified as having probable or confirmed HGE based on the outcome of serological or PCR testing. Thirty patients (median age, 44 years) were enrolled, and clinical evaluations and serum collection were undertaken at initial presentation and at 14 days, 6 to 8 weeks, and 3 to 4, 6, 12, 18, and 24 months. An indirect immunofluorescence assay (IFA) was performed, and reciprocal titers of >= 128 were interpreted as positive. Patients presented a median of 4 days after the onset of fever and were febrile for a median of 7.5 days; four (13.3%) received doxycycline. Seroconversion was observed in 3 of 30 (10.0%) patients, and 25 (83.3%) showed >4-fold change in antibody titer. PCR results were positive in 2 of 3 (66.7%) seronegative patients but in none of 27 seropositive patients at the first presentation. IFA antibody titers of >= 128 were found in 14 of 29 (48.3%), 17 of 30 (56.7%), 13 of 30 (43.4%), and 12 of 30 (40.0%) patients 6, 12, 18, and 24 months after presentation, respectively. Patients reporting additional tick bites during the study had significantly higher antibody titers at most time points during follow-up. No long-term clinical consequences were found during follow-up.

* Corresponding author. Mailing address: Department of Infectious Diseases, University Medical Centre, Japljeva 2, 1525 Ljubljana, Slovenia. Phone: (386 1) 2310 558. Fax: (386 1) 2302 781. E-mail: stanka.lotric-furlan{at}mf.uni-lj.si.

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 899-903, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.899-903.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.